多西紫杉醇
医学
内科学
肿瘤科
打开标签
随机对照试验
化疗
作者
Caicun Zhou,Dingzhi Huang,Yun Fan,Xinmin Yu,Yunpeng Liu,Yongqian Shu,Zhiyong Ma,Ziping Wang,Ying Cheng,Jie Wang,Sheng Hu,Zhihua Liu,Elena Poddubskaya,Umut Dişel,А. Л. Акопов,Mikhail Dvorkin,Wenjuan Zheng,Yiyuan Ma,Yan Wang,Songzi Li
标识
DOI：10.1016/j.jtho.2022.09.217
摘要
Tislelizumab was found to have a significantly improved and long-term clinical benefit in OS versus docetaxel in pretreated patients with advanced NSCLC, regardless of PD-L1 expression.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
haijun
Criminology34
不想当牛马
嘻嘻哈哈
cdercder
GingerF
无极微光
精明金毛
学术文献互助
molihuakai
pcr163
369ninja
xfy
缥缈淇
罗曼蒂克的蒲猫猫
Copyright
鲸鱼
arniu2008
石头巧克力
皖公网安备34019202002308
